Metformax Sr

Metformin Hydrochloride, the active ingredient in Metformax Sr, is a Biguanide presented as an oral tablet for oral use. It is used to manage type 2 diabetes mellitus in adult patients by decreasing hepatic glucose output and improving peripheral insulin sensitivity, thereby contributing to better glycaemic control.

GNH USA supplies Metformax Sr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable sourcing for healthcare providers through established distribution networks.

Metformin Hydrochloride is employed in the management of disorders related to glucose metabolism, primarily type 2 diabetes mellitus.

- Type 2 diabetes mellitus: improves glycaemic control by lowering fasting and post‑prandial blood glucose levels. - Prediabetes (impaired glucose tolerance): reduces progression to overt diabetes by enhancing insulin sensitivity. - Polycystic ovary syndrome (PCOS): helps mitigate insulin resistance, which may improve menstrual regularity and ovulation.

Metformin Hydrochloride may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite. - Diarrhea: loose stools, especially during treatment initiation. - Metallic taste: transient alteration in taste perception.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic acidosis. - Severe hypoglycemia: can occur when combined with insulin or sulfonylureas. - Hepatic dysfunction: elevated liver enzymes or hepatitis.

When prescribing Metformax Sr, clinicians should consider several safety aspects.

- Renal function: assess creatinine clearance before initiating therapy and monitor periodically. - Hepatic function: avoid use in patients with significant liver disease due to lactic acidosis risk. - Lactic acidosis risk: discontinue if patient develops unexplained acidosis, severe infection, or hypoxia. - Vitamin B12 monitoring: consider periodic testing as long‑term use may reduce B12 levels. - Alcohol consumption: advise limiting alcohol as it may increase lactic acidosis risk. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Metformax Sr can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Iodinated contrast agents: can precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: may raise metformin plasma concentrations, enhancing toxicity. - Alcohol: excessive intake heightens risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and potassium levels.